ArticleJournal of medical imaging and radiation oncology2025
What Is the Safe Observation Period Following Image-Guided Percutaneous Renal Biopsies?
Article in Journal of medical imaging and radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Performing a percutaneous kidney biopsy.World journal of nephrology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the timing, type, and severity of complications following percutaneous, image-guided renal biopsy and to determine if the current observation period of 4 h can be safely reduced.
methodsConsecutive image-guided percutaneous renal biopsies performed between 2017 and 2022 in adult patients by radiology medical staff were included. The RIS-PACS imaging systems and electronic medical records (EMR) were accessed to obtain relevant patient information and procedural reports. A retrospective analysis of the type and timing of complications was performed against patient demographics and biopsy-related variables. Probabilities were calculated for a range of observation periods to assess the proportion of complications identified by shortening the observation period from 4 h.
resultsThree hundred and thirty-two percutaneous renal biopsies were included, and 44 (13%) complications were identified within the 4 h observation. Twenty-nine complications were post-operative bleeding, of which 2 developed macroscopic haematuria, 25 peri-nephric haematoma and 2 had haemodynamic instability with either haematuria or peri-nephric haematoma. 64% of all complications occurred within the first hour, and 86% occurred within 2 h. Of the six complications occurring after 2 h, two were post-operative bleeding in non-targeted renal biopsies requiring admission, and the other four did not require additional observation/procedures.
conclusionThe vast majority of complications after targeted and non-targeted renal biopsies tend to occur within the first 2 h of observation. Complications that occurred after 2 h observation were often pain related, something that can be overcome with a standardised post-operative analgesic regime. It may be possible to safely reduce observation times following image-guided targeted renal biopsies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.